baber/WOPTO huggingface dataset:
Patent CY-1107376-T1 (CY)
Inventor: CHAUDHRY SAEED
IPC: A61K31/573
Filed: 2008-03-31
Abstract: Disclosed are methods of introducing a suspension or solution of a medicament, preferably mometasone furoate anhydrous, into a metered dose inhaler container, said container having a valve attached thereto, said method comprising the steps of introducing mometasone furoate anhydrous, a surfactant and a chlorflourocarbon free propellant into a vessel that is held under pressure to form a suspension or solution, circulating said suspension or solution from the vessel through a line which includes a filling head, bringing said filling head into communication with said metered dose inhaler container through said valve of said metered dose inhaler container, introducing a quantity of such suspension or solution into the container from the filling head of the line through said valve of said metered dose inhaler container, withdrawing said filling head from said metered dose inhaler container, and sealing said metered dose inhaler container, as well as the products produced thereby having an improved particle size distribution of the active ingredients in metered dose inhalers.
Patent CY-1107977-T1 (CY)
Inventor: COSTA UMBERTO
IPC: C04B40/06
Filed: 2008-05-30
Abstract: Described herein are new cementitious mortars with a high degree of fluidity and high final resistance. The mortars contain water, a hydraulic binder, a pozzolanic substance (finely ground slag), a fluidifier and/or superfluidifier, a setting regulator, and aggregates having a specific granulometric distribution. The aggregates are made up of three highly monogranular fractions (A, B, C), and a fourth fraction (D) having a low monogranularity. The new mortars described herein have values of fluidity higher, by approximately 70%, than those of mortars produced with traditional aggregates. The increase in fluidity is obtained without increasing the water/cement ratio and without increasing the amount of fluidifiers/superfluidifiers present. The mortars produced according to the invention may be used to advantage in all applications in which it is required to associate a high degree of fluidity and a high final mechanical resistance, both in compression and in flexure.
Patent CY-1109813-T1 (CY)
Title: Παραγωγα υδροξυαλκυλ-αμυλου
Inventor: ZANDER NORBERT
IPC: C07K17/06
Filed: 2010-02-16
Abstract: Η παρούσα εφεύρεση αφορά σύζευγμα υδροξυαλκυλ-αμύλου (HAS)-πολυπεπτιδίου που εμπεριέχει ένα ή περισσότερα μόρια HAS, όπου κάθε HAS είναι συζευγμένο στο πολυπεπτίδιο μέσω κάποιας μονάδας υδατάνθρακα ή κάποιο θειοαιθέρα, καθώς και τις μεθόδους για την παραγωγή αυτών. Σε κάποια προτιμώμενη εφαρμογή, το πολυπεπτίδιο είναι ερυθροποιητίνη (EPO).
Patent CY-1110304-T1 (CY)
Inventor: ECKERT ANNE
IPC: G01N33/50
Filed: 2010-07-14
Abstract: The invention concerns the field of transgenic animal models and more particularly, animal models of Alzheimer disease. The invention relates to a transgenic animal expressing a multiple mutated form of presenilin 1 and enabling to detect an apoptotic phenomenon in a renewable peripheral tissue.
Patent CY-1113802-T1 (CY)
Title: Διαδικασια για την παρασκευη βρωσιμων ζυμαρικων με υψηλη απορροφηση ουσιων, μια σχετικη διαταξη επεξεργασιας της ζυμης και τα ζυμαρικα που λαμβανονται κατ' αυτον τον τροπο
Inventor: RANA GIOVANNI
IPC: A21C11/12
Filed: 2013-03-13
Abstract: Μία διαδικασία για την παρασκευή βρώσιμης ζύμης με υψηλή απορρόφηση ουσιών, περιλαμβάνει τουλάχιστον μία φάση σχηματισμού ενός φύλλου ζύμης (11) και μία φάση εντομής του φύλλου σε τουλάχιστον μία πλευρά, όπου η εντομή, που διεξάγεται μέσω ελασματοποίησης, δημιουργεί μία σειρά ραβδώσεις ή διάκενα (16) σε όλη την επιφάνεια του φύλλου (11) και έχει βάθος το οποίο καταλαμβάνει μέρος του πάχους του φύλλου (11).
Patent CY-1114479-T1 (CY)
Title: Φαρμακολογικη επικουρικη αγωγη σε συνδυασμο με διηθητικη χειρουργικη επεμβαση γλαυκωματος
Inventor: BARTELS STEPHEN P
IPC: A61K31/00
Filed: 2013-09-18
Abstract: Σύνθεση για έλεγχο ή αποτροπή εξέλιξης γλαυκώματος περιλαμβάνει υλικό που μειώνει ή αναστέλλει την παραγωγή ισόμορφης ΤGF-β ή χημειοκίνης ή κυτοκίνης που διεγείρει την έκφραση ισόμορφης ΤGF-β. Το υλικό μπορεί να περιλαμβάνει διαχωρισμένο αγωνιστή υποδοχέα γλυκοκορτικοειδούς (“DIGRA”: dissociated glucocorticoid receptor agonist), προφάρμακο αυτού, φαρμακευτικά αποδεκτό άλας αυτού, ή φαρμακευτικά αποδεκτό εστέρα αυτού. Η σύνθεση μπορεί επιπλέον να περιλαμβάνει ανταγωνιστή του ΤGF-β. Χορηγείται σε ασθενή που έχει υποβληθεί σε διηθητική χειρουργική επέμβαση γλαυκώματος για να εξασφαλίσει λειτουργική διηθητική φυσαλίδα μετά από τέτοια χειρουργική επέμβαση.
Patent CY-1117383-T1 (CY)
Title: Αυτοματος εγχυτηρας
Inventor: YOUNG MATTHEW EGERTON
IPC: A61M5/32
Filed: 2016-03-02
Abstract: Προτείνεται ένας αυτόματος εγχυτήρας για τη διανομή προκαθορισμένης δόσης φαρμάκου. Ο αυτόματος εγχυτήρας περιέχει κάλυμμα της βελόνας που διαμορφώνεται κατά τρόπον ώστε να μετακινείται από οπίσθια θέση σε κλειδωμένη θέση έκτασης. Ο αυτόματος εγχυτήρας περιέχει ένα πρώτο συγκρότημα κλειδώματος για τη συγκράτηση του καλύμματος της βελόνας σε οπίσθια θέση κλειδώματος και ένα δεύτερο συγκρότημα κλειδώματος για τη συγκράτηση του καλύμματος της βελόνας σε κλειδωμένη θέση έκτασης.
Patent CY-1121573-T1 (CY)
Title: Συζευγμα αντισωματος anti-her2-φαρμακου
Inventor: NAITO HIROYUKI
IPC: A61P35/00
Filed: 2019-04-11
Abstract: Ως ένα φάρμακο κατά των όγκων που έχει μια εξαιρετική επίδραση κατά των όγκων και που έχει επίσης και μια εξαιρετική θεραπευτική επίδραση, ένα σύζευγμα αντισώματος-φαρμάκου παρέχεται, το οποίο χαρακτηρίζεται από το γεγονός ότι μια ένωση κατά των όγκων αναπαρίσταται από χημικό τύπο (1) συνδέεται σε ένα αντίσωμα αντι-ΗΕR2 μέσα από ένα συνδέτη έχοντας μια δομή που αναπαρίσταται από χημικό τύπο: -L1-L2-LP-NH-(CH2)n1-La-(CH2)n2-C(=O)- (όπου το αντίσωμα αντι-ΗΕR2 συνδέεται στο τερματικό του L1, και η ένωση κατά των όγκων συνδέεται σε μια ομάδα καρβονυλίου σε μια μερίδα -(CH2)n2-C(=O)- όπου ένα άτομο αζώτου σε μια αμινομάδα που εντοπίζεται στη θέση-1 στην ένωση κατά των όγκων χρησιμεύει ως ένα μέρος σύνδεσης).
Patent CY-1125283-T1 (CY)
Title: Επιδιαλυτωμενο ν-{3-[3-κυκλοπροπυλο-5-(2-φθορο-4-ιωδοφαινυλαμινο)-6,8-διμεθυλο-2,4,7-τριοξο-3,4,6,7-τετραϋδρο-2η-πυριδο[4,3-d]πυριμιδιν-1-υλο]-φαινυλο}-κυκλοπροπανοκαρβοξαμιδο διμεθυλοσουλφοξειδιο ως ενας αναστολεας μεκ1/2
Inventor: REPIK ALEXEY EVGENIEVICH
IPC: C07D471/04
Filed: 2021-11-15
Abstract: Ο στόχος της παρούσας εφεύρεσης είναι να δημιουργήσει καινοφανείς αναστολείς ΜΕΚ1, ΜΕΚ2 και ΜΕΚ1/2 που έχουν χαμηλότερη τοξικότητα σε μακρόχρονη δοσολογία. Αυτός ο στόχος επιτυγχάνεται με την καινοφανή ένωση επιδιαλυτωμένο Ν-{3-[3-κυκλοπροπυλο-5-(2-φθορο-4-ιωδοφαινυλαμινο)-6,8-διμεθυλο-2,4,7-τριοξο-3,4,6,7-τετραϋδρο-2H-πυριδο[4,3-d]πυριμιδιν-1-υλο]-φαινυλο}-κυκλοπροπανοκαρβοξαμιδο διμεθυλοσουλφοξείδιο με τύπο 1.
Patent GR-890300075-T1 (GR)
Title: Microbicides
Inventor: JANICKE REINHARD DR
IPC: A01N43/84
Filed: 1989-09-29
Abstract: 1. A composition for controlling phytopathogenic fungi and for preventing fungus attack based on a mixture of two plant fungicides in admixture with a suitable carrier and/or extender, wherein the composition contains as component l the active ingredient 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylme- thyl]-1H- 1,2,4-triazol (= propiconazol) of formula l   see diagramm : EP0237483,P7,F1   or a salt thereof and as component ll the active ingredient 4-[3-(4-tert. butylphenyl)-2-methylpropyl]-cis-2,6-dimethylmorpholine (= fenpropimorph) of formula ll   see diagramm : EP0237483,P7,F2   or a salt thereof in an amount producing synergistic fungicidal activity.
Patent HR-P20090403-T1 (HR)
Inventor: CHU ZHI-LIANG
IPC: A61P3/00
Filed: 2009-07-16
Abstract: Ex vivo postupak identifikacije GLP-1 sekretogoga, naznačen time, da obuhvaća (a)	stavljanje u kontakt test spoja sa stanicom domaćina ili membranom stanice domaćina koja izlučuje G protein-kupiran receptor pri čemu navedeni G protein kupirani receptor obuhvaća aminokiselinsku sekvencu izabranu iz skupine koju čine: (i)	aminokiseline 1-335 SEQ ID br. 2; (ii)	aminokiseline 2-335 SEQ ID br. 2; (iii)	aminokiselinska sekvenca G protein-kupiranog receptora kodirana pomoću polinukleotida koji sadrži nukleotidnu sekvencu gdje je navedena nukleotidna sekvenca hibridizirana pod strogo kontroliranim uvjetima prema komplementarnoj SEQ ID br. 1; te (iv)	biološki aktivan fragment G protein-kupiranog receptora bilo kojeg (i) do (iii); te (b)	određivanje sposobnosti test spoja da stimulira funkcionalnost receptora preko mjerenja nivoa drugog glasnika izabranog iz skupine koju čine ciklički AMP (cAMP), ciklički GMP (cGMP), inositol 1,4,5-trifosfat (IP3), diacilglicerol (DAG), aktivnost MAP kinaze, aktivnost MAPK/ERK kinaza kinaza 1 (MEKK1), te Ca2+; ili preko uporabe Melanophore ispitivanja, preko uporabe ispitivanja izvješća ili preko mjerenja vezivanja GTPγS na membranu koja sadrži navedeni GPCR; pri čemu je sposobnost test spoja da stimulira funkcionalnost receptora indikativna da je test spoj GLP-1 sekretogog; (c)	stavljanje u kontakt spoja koji stimulira funkcionalnost receptora u koraku (b) in vitro s enteroendokrinom stanicom sisavca; te (d)	određivanje da li spoj stimulira GLP-1 sekreciju iz enteroendokrine stanice sisavca; pri čemu je sposobnost test spoja da stimulira GLP-1 sekreciju iz enteroendokrine stanice sisavca nadalje indikativna da je test spoj GLP-1 sekretogog. Patent sadrži još 41 patentni zahtjev.
Patent HR-P20110441-T1 (HR)
Inventor: DORSCH DIETER
IPC: A61K31/501
Filed: 2011-06-14
Abstract: Spojevi prema formuli I naznačeni time daR1	označava H ili A, R2	označava nezasićeni, zasićeni ili aromatski 5- ili 6-člani heterocikal koji ima 1 do 4 N, O i/ili S atoma, koji mogu biti nesupstituirani ili mono-, di- ili tri-supstituirani sa Hal, A, [C(R3)2]nOR3, N=CR3N(R3)2, SR3, NO2, CN, COOR3, CON(R3)2, NR3COA, NR3SO2A, SO2N(R3)2, S(O)mA, [C(R3)2]nN(R3)2, [C(R3)2]nHet, O[C(R3)2]nN(R3)2, O[C(R3)2]nHet, S[C(R3)2]nN(R3)2, S[C(R3)2]nHet, NR3[C(R3)2]nN(R3)2, NR3[C(R3)2]nHet, NHCON(R3)2, NHCONH[C(R3)2]nN(R3)2, NHCONH[C(R3)2]nHet, [C(R3)2]nNHCO[C(R3)2]nN(R3)2, [C(R3)2]nNHCO[C(R3)2]nHet, CON(R3)2, CONR3[C(R3)2]nN(R3)2, CONR3[C(R3)2]nNR3COOA, CONR3[C(R3)2]nOR3, CONR3[C(R3)2]nHet, COHet, COA i/ili =O (karbonil kisik), R3	označava H ili A, R4,R4'	svaki, nezavisno jedan od drugoga, označava H, Hal, A, OR3, CN, COOR3, CON(R3)2, NR3COA, NR3SO2A, SO2N(R3)2 ili S(O)mA, Ar	označava fenil, naftil ili bifenil, svaki od kojih je nesupstituiran ili mono-, di- ili tri-supstituiran sa Hal, A, [C(R3)2]nOR3, [C(R3)2]nN(R3)2, SR3, NO2, CN, COOR3, CON(R3)2, NR3COA, NR3SO2A, SO2N(R3)2, S(O)mA, CO-Het, Het, O[C(R3)2]nN(R3)2, O[C(R3)2]nHet, NHCOOA, NHCON(R3)2, NHCOO[C(R3)2]nN(R3)2, NHCOO[C(R3)2]nHet, NHCONH[C(R3)2]nN(R3)2, NHCONH[C(R3)2]nHet, OCONH[C(R3)2]nN(R3)2, OCONH[C(R3)2]nHet, CONR3[C(R3)2]nN(R3)2, CONR3[C(R3)2]nHet i/ili COA, Het	označava a mono-, bi- ili triciklički zasićeni, nezasićeni ili aromatski heterocikal koji ima 1 do 4 N, O i/ili S atoma, koji mogu biti nesupstituirani ili mono-, di- ili tri- supstituirani sa Hal, A, [C(R3)2]nOR3, [C(R3)2]nN(R3)2, SR3, NO2, CN, COOR3, CON(R3)2, NR3COA, NR3SO2A, SO2N(R3)2, S(O)mA, CO-Het1, [C(R3)2]nHet1, O[C(R3)2]n- N(R3)2, O[C(R3)2]nHet1, NHCOOA, NHCON(R3)2, NHCOO[C(R3)2]nN(R3)2, NHCOO[C(R3)2]nHet1 NHCONH[C(R3)2]nN(R3)2, NHCONH[C(R3)2]nHet1, OCONH[C(R3)2]nN(R3)2, OCONH[C(R3)2]nHet1, CO-Het1, CHO, COA, =S, =NH, =NA i/ili =O (karbonil oksi- gen), Het1	označava monociklički zasićeni heterocikal koji ima 1 do 2 N i/ili O atoma, koji mogu biti mono- ili di-supstituirani sa A, OA, OH, Hal i/ili =O (karbonil kisik), A	označava nerazgranati ili razgranati alkil koji ima 1-10 C atoma, gdje 1-7 H atoma mogu biti zamijenjeni sa F i/ili gdje jedna ili dvije ne-susjedne CH2 skupine mogu biti zamijenjene sa O NH, S, SO, SO2 i/ili sa CH=CH skupinama, ili cikličkim alkilom koji ima 3-7 C atoma, Hal	označava F, Cl, Br ili I, m 	označava 0, 1 ili 2, n 	označava 0, 1, 2, 3 ili 4, i njihove farmaceutski korisne soli, tautomeri i stereoizomeri, uključujući njihove mješavine u svim omjerima. Patent sadrži još 15 patentnih zahtjeva.
Patent SI-1553944-T1 (SI)
Title: Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist
Inventor: SCHUTZE FRANCOIS
IPC: A61K31/00
Filed: 2003-10-21
Abstract: Composition comprises at least one histamine H2 receptor antagonist and tenatoprazole or its potassium, magnesium, sodium or calcium salts.
Patent SI-1641933-T1 (SI)
Title: Process for the preparation of cephradine
Inventor: LENHARDT CARLOS ENRIQUE
IPC: C12P35/00
Filed: 2004-07-01
Abstract: The present invention describes a process for preparing cephradine, said process comprising reacting 7-aminodesacetoxy cephalosporanic acid (7-ADCA) with D-dihydrophenylglycine in activated form (DHa) in the presence of an enzyme in a reaction mixture to form cephradine, resulting in a conversion of 7-ADCA into cephradine of at least 70 %, wherein the concentration D-dihydrophenylglycine (DH) in the reaction mixture is below 2 wt.%, wherein the conversion of 7-ADCA into cephradine = (nCEF/ n7-ADCA) *100%, wherein nCEF=quantity of cephradine formed (in mole); and n7-ADCA =total quantity of 7-ADCA added to reaction mixture (in mole). The invention also describes a process for the preparation of cephradine hydrate characterised in that the process comprises: - reacting 7-amino acid desacetoxy cephalosporanic acid (7-ADCA) with DHa in the presence of an enzyme in a reaction mixture to form cephradine; - preparing an aqueous solution comprising at least part of the cephradine; and crystallising the cephradine from said aqueous solution. The invention further describes cephradine hydrate obtainable by a process according to invention. The invention also describes cephradine hydrate with an absorbance at 450 nm of below 0.050.
Patent SI-1562098-T1 (SI)
Title: Selective actuation device
Inventor: MARCACCI MAURIZIO
IPC: F16D65/18
Filed: 2005-02-01
Abstract: Selective actuation device (1) comprising and actuator (5) acting upon an actuation lever (7) that has at least one thrusters element (7b) for the actuation of a first operating group (12, 13) and a cam element (6) mobile between an activation position in which it acts upon a second operating group (9, 10) and a rest position in which the activation of the first operating group (12, 13) is disassociated from the second operating group (9, 10). <IMAGE>
Patent SI-2287073-T1 (SI)
Title: Vertical wind tunnel frefall simulator
Inventor: METNI N ALAN
IPC: B64D23/00
Filed: 2005-08-01
Abstract: A cable designed for use in applications when it is advantageous to reduce the amount of aerodynamic drag in air caused by the cable without the cable being formed from a multiplicity of a plurality of elongated metal elements twisted together, one of said outer elements having a cross-section which is different to all other outer elements, said all other outer elements defining an outer surface of the line which has a predetermined circumferential length, said one element having a cross-sectional size and shape such that it projects or indents from said outer surface a distance above or below said predetermined circumferential length so as to form a helical ridge or grove around the line, thereby reducing the aerodynamic drag of the cable in air.
Patent SI-1973896-T1 (SI)
Title: A process for the preparation of the (s)-enantiomer of omeprazole
Inventor: DOMINGO COTO ANTONIO
IPC: C07D401/00
Filed: 2006-12-18
Abstract: A process for the preparation of (S)-omeprazole from racemic omeprazole via the formation of an inclusion complex with (S)-1,1,2-triphenyl-1,2-ethanediol. (S)-Omeprazole is recovered in a substantially optically pure form either in neutral form or as a pharmaceutically acceptable salt or as its solvates including hydrates. The (S)-omeprazole 2[(S)-1,1,2-triphenyl-1,2-ethanediol] inclusion complex is new. This resolution process proceeds with high yields and high optical purity.
Patent SI-1907371-T1 (SI)
Title: Process for preparing 2-methoxycarbonylmethyl-6,6-dimethyl-2- tetrahydropyran carboxylic acid
Inventor: FERRARI MASSIMO
IPC: C07C211/00
Filed: 2006-07-14
Abstract: Process for preparing 2-methoxycarbonylmethyl-6,6-dimethyl-2-tetrahydropyran carboxylic acid (I) comprising: a) Reaction of 5-bromo-2-methyl-2-pentene (III) with magnesium and then diethyloxalate to obtain ethyl-2-oxo-6-methyl-5-heptenoate (IV); b) Reaction of ethyl-2-oxo-6-methyl-5-heptenoate (IV) with an alkali amide and methyl acetate to obtain ethyl-2-methoxycarbonylmethyl-2-hydroxy-6-methyl-5-heptenoate (V); c) Reaction of ethyl-2-methoxycarbonylmethyl-2-hydroxy-6-methyl-5-heptenoate (V) with an alkali metal hydroxide to obtain the corresponding 2-carboxymethyl-2-hydroxy-6-methyl-5-heptenoic acid (VI); d) Cyclisation of 2-carboxymethyl-2-hydroxy-6-methyl-5-heptenoic acid (VI) with formic acid to give 2-carboxymethyl-6,6-dimethyl-2-tetrahydropyrancarboxylic acid (VII); e) Monoesterification of 2-carboxymethyl-6,6-dimethyl-2-tetrahydropyrancarboxylic acid (VII) to 2-methoxycarbonylmethyl-6,6-dimethyl-2-tetrahydropyran carboxylic acid (I), characterised in that in stage (e) the 2-methoxycarbonylmethyl-6,6-dimethyl-2-tetrahydropyran carboxylic acid (I) is purified by means of the formation of the corresponding salt with cyclohexylamine (IA).
Patent GR-20010300036-T1 (GR)
Title: Distribution of requested video sequences via satellites
Inventor: GEILING REINHOLD
IPC: H04H20/00
Filed: 2001-07-31
Abstract: The invention relates to the distribution of requested video sequences via satellite, especially music video clips. In order to easily and reliably distribute requested video sequences with professional quality to individual authorized receivers with minor load on the transmission paths and low transmission costs, the computer (1) has a receiver-specific identification (4). The video sequence (5) is distributed to the satellite receiver (13) within a packet-switching data service and stored in the storage unit (15) of the computer (1). The computer (1) includes an MPEG-2 decoder(15) for real time decoding of MPEG-2 files representing the video sequences into a video signal (18). In an advantageous embodiment, real time decoding is successfully conducted only when a video provider-specific reproduction software (16) is used, wherein decoding of the MPEG-2 files is carried out in real time using a video provider-specific key (17) without storing uncoded video sequences (5).
Patent DE-3686651-T2 (DE)
Inventor: BAHL LALIT RAI
IPC: G10L15/14
Filed: 1986-03-27
Granted: 1993-04-01
Abstract: Method and apparatus for statistically determining in a vocabulary of words at least one word which has a relatively high probability of having generated a string of incoming labels produced in response to a speech input. Each word is represented as a sequence of phonetic elements (including conventional phones) wherein the statistical representations of the phonetic elements are simplified by approximations. In a first approximation, the actual probabilities that a given phonetic element generates a given label (at any of various transitions ti between states Sj in the given phonetic element) are replaced by a single specific value which is no less than the maximum actual probability for the given label in the given phonetic element. A second approximation provides that the probability of a given phonetic element to generate any length of labels between a minimum and a maximum is uniform. A third approximation provides that only a maximum number of labels be examined in forming a match value for any phonetic element.
Patent DE-3688248-T2 (DE)
Inventor: FISHER F
IPC: C12P17/18
Filed: 1986-08-26
Granted: 1993-07-15
Abstract: A system for the production of biotin wherein a biotin retention-deficient strain of a cell is transformed with plasmid bearing the biotin gene cluster bio (A, B, F, C and D). The media of cultures of the resulting cells contains enhanced amounts of biotin by comparison with similar constructions in strains capable of biotin retention.
Patent DE-3750089-T2 (DE)
Inventor: INGWALL RICHARD
IPC: G03H1/02
Filed: 1987-12-18
Granted: 1994-10-13
Abstract: Volume phase holograms and other holographic elements which include microscopic areas of a material having an index of refraction different from that of the holographic fringes.
Patent DE-3786241-T2 (DE)
Inventor: KEEFER RICHARD MACKAY
IPC: G12B17/02
Filed: 1987-12-15
Granted: 1993-10-07
Abstract: For determining the attainment of a desired heated condition, referred to as "doneness", of a body of food or other material heated in a microwave oven, there is provided a device including an indicator that changes appearance at a predetermined temperature, mounted on an outwardly-facing major surface of a thin-gauge metal element (22) which is disposed in the oven so as to receive heat from the body. The metal element may be mounted on the lid (18) or other wall of a container (10) holding the body (11) in the oven (not shown); the lid may be microwave-transmissive and may hold the metal element (22) spaced above the body (11). The indicator may include a multilayer structure (28) which has the property of undergoing an observable change of appearance upon attaining a predetermined elevated temperature. In use, the device is placed in a microwave oven together with the body (11) and is observed visually, for detection of the change of appearance, which occurs when the indicator reaches a temperature corresponding to adequate doneness of the body (11).
Patent DE-3850031-T2 (DE)
Inventor: MOUISSIE BOB
IPC: H01R24/00
Filed: 1988-10-14
Granted: 1995-02-02
Abstract: Pin holder for a separable electronic plug connection, having a number of resilient lips (5) which are formed on the holder (1) and are provided at their free ends with an inwardly protruding hook-shaped part (6), and outwardly directed protruding parts (11) which are formed on the pin carrier (8) and, in the assembled state, engage behind the hook-shaped parts (6), the said one parts being provided with obliquely running contact surfaces (6 min ). Preferably stopping means are formed by at least one shoulder (7) inside the holder (1), whereas in the holder there is an intermediate wall (12) which is provided with openings through which the pins (10) extend.
Patent DE-3881073-T2 (DE)
Inventor: CONNOR DAVID THOMAS
IPC: C07D257/06
Filed: 1988-02-19
Granted: 1993-09-02
Abstract: Novel naphthalene derivatives of the formula (I): <CHEM> having antiallergy and antiinflammatory activity. E
Patent TR-199800245-T2 (TR)
Inventor: CAMDEN JAMES BERGER
IPC: A61K31/513
Filed: 1996-07-30
Abstract: Memelilerde kanserlerin ilerlemesini ve tümörlerin yayilmasini önleyen ve bir 1H-1,2,4-triazol türeviyle birlikte bir kemoterapötik maddenin güvenli ve etkin bir miktarini ihtiva eden bir farmasötik bilesim.
Patent TR-199801100-T2 (TR)
Inventor: KUMMERMEHR HANS
IPC: C03C13/06
Filed: 1996-12-13
Abstract: Isiya dirençli mineral yün ürün özellikle cam liflerden olusur, ayirt edici özelligi lifler plastik disi halde iken ürünün en azindan bir dis tabakasinin lifleri üzerine ince inorganik parçaciklar eklenir, sözü edilen ince inorganik parçaciklar, sözü edilen ürün isiya tabi tutuldugunda liflerin kristallestirme egilimini artirir.
Patent TR-199801305-T2 (TR)
Inventor: DICKENS R ROBERT
IPC: C03B29/06
Filed: 1997-01-06
Abstract: A spout forming assembly for glassware and a method therefor in which the assembly includes a spout forming device for forming a pour spout on the edge of a piece of glassware, an actuation device for actuating the forming device, and a control device for controlling the actuation device. The method generally includes the steps of: (a) moving a piece of glassware having an edge along a predetermined path; (b) heating the edge; and (c) engaging the edge with forming means to form a spout on the edge of the glassware.